Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结、球孢子菌病、传染性胞增多症、形虫病、肉、巴和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性巴上皮病变、转移或浸润性低分化鳞癌及恶性巴进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金巴的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结、球孢子菌病、传染细胞增多症、形虫病、肉样、和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良上皮病变、转移或浸润低分化鳞癌及恶进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样瘤、淋巴瘤和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性淋巴上皮病变、转移或浸润性低分化鳞癌及恶性淋巴瘤进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金淋巴瘤的疗。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样瘤、淋巴瘤和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性淋巴上皮病变、转移或浸润性低分化鳞癌及恶性淋巴瘤进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的合方案治疗非霍奇金淋巴瘤的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样瘤、淋巴瘤和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性淋巴上皮病变、转或浸润性低分化鳞癌及恶性淋巴瘤别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金淋巴瘤的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样瘤、巴瘤和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性巴上皮病变、转移或浸润性低分化鳞癌及恶性巴瘤进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金巴瘤的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手死,上腔静脉梗阻症状均明显改善。1例人造血管血栓形成,经溶栓治疗痊愈。全组患者存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样、淋巴和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性淋巴上皮病变、转移或浸润性低分化鳞癌及恶性淋巴进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目评估表柔比星为主方案治疗非霍奇金淋巴疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样、淋巴和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性淋巴上皮病变、转移或浸润性低分化鳞癌及恶性淋巴进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目评估表柔比星为合方案治疗非霍奇金淋巴疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造血管血栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

Bilateral cervical adenopathy is also prominent in tuberculosis coccidioidomycosis infectious mononucleosis toxoplasmosis sarcoid lymphomas and leukemias.

双侧颈部腺病在结核、球孢子菌病、传染性单核细胞增多症、形虫病、肉样、和白血病。

The diagnosis should be differentiated with benign lymphoepithelioma, metastasis or infiltrated poorly differentiated squamous cell carcinoma and malignant lymphoma.

诊断应与良性上皮病变、转移或浸润性低分化鳞癌及恶性进行鉴别。

Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.

目的评估表柔比星为主的联合方案治疗非霍奇金的疗效。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手,后上腔静脉梗阻症状均明显改善。1例后人造血管血栓形成,经溶栓治疗后痊愈。全组患者后存活时间为6～30个月。